Cloning and characterization of steroid 5β-reductase from the venom gland of Bufo bufo gargarizans

Yanan Zhang,Xue Li,Di Xu,Mengyun Wu,Yinghui Dai,Mingyu Xia,Dong Wang
DOI: https://doi.org/10.1016/j.ijbiomac.2021.01.211
IF: 8.2
2021-04-01
International Journal of Biological Macromolecules
Abstract:<p>Bufadienolides are the main active ingredients of Venenum Bufonis, which is a widely used traditional Chinese medicine secreted from parotoid gland and skin glands of <em>Bufo bufo gargarizans</em>. According to the transcriptome analysis, "cholesterol-bile acid-bufadienolidies pathway" was proposed as animal-derived bufadienolides biosynthesis pathway by us previously. In this pathway 3<em>β</em>-hydroxysteroid dehydrogenase (3<em>β</em>HSD) and steroid 5<em>β</em>-reductase (SRD5<em>β</em>) might be the key enzymes to convert the A/B ring to <em>cis</em>-configuration. Therefore, as the second report of our group, here we report the cloning of the full length of SRD5<em>β</em> cDNA of <em>B. bufo gargarizans</em> (<em>Bbg</em>-<em>SRD5β</em>) from the parotoid gland of <em>B. bufo gargarizans</em> for the first time, and site-directed mutagenesis was used to explored the character of <em>Bbg</em>-SRD5<em>β</em>. <em>Bbg</em>-SRD5<em>β</em> had an open reading frame of 981 bp and encoded 326 amino acids residues. The expression conditions of the recombinant <em>Bbg</em>-SRD5<em>β</em> in <em>E. coli</em> BL21 (DE3) harbored with pCold-<em>Bbg</em>-SRD5<em>β</em> was optimized as induction for 10 h at 15 °C with 0.1 mM IPTG. With NADPH as a cofactor, <em>Bbg</em>-SRD5<em>β</em> can reduce the Δ<sup>4,5</sup> double bonds of progesterone to generate dihydroprogesterone õwithout substrate inhibition effect. The catalytic rate of mutant type <em>Bbg</em>-SRD5<em>β</em>-Y132G was 1.8 times higher than that of wild type <em>Bbg</em>-SRD5<em>β</em>. Although <em>Bbg</em>-SRD5<em>β</em> was almost unable to reduce the progesterone to dihydroprogesterone after mutation of V309, the affinity of enzyme with NADPH changed significantly. <em>Bbg</em>-SRD5<em>β</em> is the key enzymes to convert the A/B ring of steroid to <em>cis</em>-configuration, and V309 is a key site affecting the binding affinity of enzyme with NADPH, and the mutation of Y132 can adjust the catalytic rate of <em>Bbg</em>-SRD5<em>β</em>.</p>
polymer science,biochemistry & molecular biology,chemistry, applied
What problem does this paper attempt to address?